Outcome of Board Meeting held on 07 th March 2026, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The filing is announced as the outcome of a board meeting held on 07 March 2026 by Kabra Drugs Ltd, disclosed under SEBI's Listing Obligations and Disclosure Requirements. However, the actual document content could not be retrieved — the BSE page returned an error ('The Page you are looking for has been moved') and no details of resolutions, approvals, financial results, or other board decisions are available in the provided text. As a result, the specific outcomes of the meeting cannot be summarised from this source.
No impact on shareholders or stock price can be assessed because the actual content of the board meeting outcome is missing. Investors should check the BSE corporate announcements section directly or the company's filings for the full details.